Anaergia, Inc. · TSX:ANRG
Anaergia — Q3 2024 Earnings Presentation
12 slides from Anaergia's earnings presentation, Nov 14, 2024
Slide 1: Anaergia Reports Third Quarter 2024 Financial Results - Investor Conference Call
Anaergia Inc. Anaergia Reports Third Quarter 2024 Financial Results - Investor Conference Call November 14, 2024 TSX: ANRG Fueling a Sustainable World
Slide 2: Participating in Today's Call
Participating in Today’s Call Assaf Onn Greg Wolf Dr. Yaniv Scherson Chief Executive Officer Chief Financial Officer Chief Operating Officer 2
Slide 3: Disclaimers
Disclaimers Forward-Looking Information Certain statements in this presentation and certain oral statements made by senior management during the earnings conference call on November 11, 2024 (collectively, this "presentation") are “forward-looking information” within the meaning of applicable Canadi
Slide 4: Anaergia 2.0 - A New Era of Positive Transformation & Growth
Anaergia 2.0 - A New Era of Positive Transformation & Growth • Significant shifts • New Management Team Announcements: • Ohad Epschtein, Chairman of the Board [July 10, 2024] • Ronen Kantor, Director [February 2, 2024] • Assaf Onn, Director and Chief Executive Officer [August 13, 2024] • Gregory Wol
Slide 5: Anaergia 2.0 - A New Era of Positive Transformation & Growth
Anaergia 2.0 - A New Era of Positive Transformation & Growth Capital Sales, BOO Strategy, and Global Expansion: • Our capital sales pipeline is strengthening with recent new activity, and we believe the financial impact of this will be noticeable in future periods • Advancing towards new capital-lig
Slide 6: Financial Overview Q3 2024
Financial Overview Q3 2024 Operating Results • Adj. EBITDA Q3 2024: $(6.4) million; Q3 2023: $(11.1) million • Loss from Operations Q3 2024: $10.9 million; Q3 2023: $13.3 million • Net loss Q3 2024: $15.6 million; Q3 2023: $30.6 million • Cash increased Q3 2024: $40.2 million; Q3 2023: $22.1 million
Slide 7: Q3 Financial Results
Q3 Financial Results • Q3 2024 Revenue decreased 14.5% compared to 2023 primarily due to Italian Capital Sales projects being completed, some projects YTD facing customer delays, and an interim delay in new project signing (CAD millions) Q3 2024 Q3 2023 YTD (restated) 2023 2024 (restated) • Gross ma
Slide 8: Project Developments and Operational Highlights
Project Developments and Operational Highlights Riverside Water Quality Control Plant Upgrade: • Awarded C$13.3 million technology supply contract with the City of Riverside, California to upgrade the Riverside Water Quality Control Plant (RWQCP), enhancing its capacity to convert organic waste and
Slide 9: Project Developments and Operational Highlights
Project Developments and Operational Highlights Michigan State University • Contract award to upgrade the South Campus Anaerobic Digester (SCAD) at Michigan State University, one of the largest on-campus anaerobic digesters in North America. This enhancement will enable the facility to process addit
Slide 10: Project Developments and Operational Highlights
Project Developments and Operational Highlights BOO Facilities • SoCal Biomethane, California – continued stable operations injecting RNG into the pipeline • Rhode Island Bioenergy Facility – continued operations and ramp up, injecting RNG into the pipeline • Development pipeline continues to advanc
Slide 11: Closing Remarks
Closing Remarks Commitment to Financial Discipline and Growth: • We’re encouraged by the progress we’ve made in a short amount of time and excited about the opportunities that we see ahead • A new focus on disciplined growth. Anaergia is on a clear path to becoming a stronger, more agile company pos
Slide 12: Thank you
Thank you 12